Literature DB >> 20607875

Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats.

Jeffrey S Kroin1, Asokumar Buvanendran, Dana K Williams, Brian Wagenaar, Mario Moric, Kenneth J Tuman, James M Kerns.   

Abstract

BACKGROUND AND OBJECTIVES: A concern for anesthesiologists is whether local anesthetics are more toxic to peripheral nerves in diabetic patients. A previous study in streptozotocin-induced diabetic rats showed that larger doses of lidocaine produce moderate nerve injury after nerve block in normal rats and worse injury in diabetic rats. However, it is not clear whether a smaller local anesthetic dose that produces negligible nerve fiber damage in normal rats will produce significant nerve damage in diabetic rats and if adding adjuvant drugs modulates this effect.
METHODS: Rats were intravenously injected with 50 mg/kg streptozotocin to induce diabetes (blood glucose levels 9250 mg/dL) and diabetic neuropathy. After waiting 35 days, an injection (0.1 mL) of 1% lidocaine alone, or with 5 kg/mL epinephrine or 7.5 kg/mL clonidine added, or 0.5% ropivacaine alone was performed at the left sciatic notch in both diabetic and nondiabetic rats. The duration of sensory (pin prick) and motor (toe spreading reflex) nerve block in the hind paws was determined.For histologic controls, all rats also received saline vehicle injection into the right sciatic notch. Another group of uninjected rats was used as naive controls. Left and right nerves were removed 2 days after injection and fixed in situ with a 4% glutaraldehyde solution. Myelinated axon profiles suggestive of neuropathy (myelin figures, pale and swollen,or dark-staining axoplasm) were counted and expressed as a percentage of the total number of fibers in each rat sciatic nerve.
RESULTS: All streptozotocin-injected rats became diabetic and had pronounced tactile allodynia. All rats had sensory and motor nerve blocks lasting for at least 50 mins after injection of local anesthetic. The duration of sensory and motor nerve block was longer in diabetic rats than in nondiabetic rats for all drug groups tested. None of the sciatic nerves examined showed greater than 3% nerve fiber degeneration. Although lidocaine in diabetic rats did not produce nerve fiber damage,diabetic rats receiving lidocaine/clonidine or ropivacaine had more abnormal myelinated axon profiles than did nondiabetic rats receiving the same drug.
CONCLUSIONS: The duration of sciatic nerve block with local anesthetics is longer in diabetic compared with nondiabetic rats. A small, but statistically significant, increase in nerve damage occurred in diabetic rats after nerve block with ropivacaine alone or when duration of lidocaine block was extended with clonidine. These findings may have implications for dosing of local anesthetics in diabetic patients undergoing regional analgesia with nerve blocks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607875     DOI: 10.1097/aap.0b013e3181e82df0

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  25 in total

1.  Subclinical neuropathy in diabetic patients: a risk factor for bilateral lower limb neurological deficit following spinal anesthesia?

Authors:  Darshan S Angadi; Ajit Garde
Journal:  J Anesth       Date:  2011-10-16       Impact factor: 2.078

2.  In Zucker diabetic fatty rats, subclinical diabetic neuropathy increases in vivo lidocaine block duration but not in vitro neurotoxicity.

Authors:  Philipp Lirk; Magdalena Flatz; Ingrid Haller; Barbara Hausott; Stephan Blumenthal; Markus F Stevens; Suzuko Suzuki; Lars Klimaschewski; Peter Gerner
Journal:  Reg Anesth Pain Med       Date:  2012 Nov-Dec       Impact factor: 6.288

3.  Possible utility of contrast-enhanced ultrasonography for detecting spread of local anesthetic in nerve block.

Authors:  Hideaki Sasaki; Masanori Yamauchi; Takafumi Ninomiya; Haruyuki Tatsumi; Michiaki Yamakage
Journal:  J Anesth       Date:  2017-04-03       Impact factor: 2.078

4.  Primary payer status is associated with the use of nerve block placement for ambulatory orthopedic surgery.

Authors:  Patrick J Tighe; Meghan Brennan; Michael Moser; Andre P Boezaart; Azra Bihorac
Journal:  Reg Anesth Pain Med       Date:  2012 May-Jun       Impact factor: 6.288

5.  Comparison of pulpal anesthesia and cardiovascular parameters with lidocaine with epinephrine and lidocaine with clonidine after maxillary infiltration in type 2 diabetic volunteers.

Authors:  Marija S Milic; Bozidar Brkovic; Elena Krsljak; Dragica Stojic
Journal:  Clin Oral Investig       Date:  2015-10-01       Impact factor: 3.573

6.  Toward a potential paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rodent model.

Authors:  Brian A Williams
Journal:  Reg Anesth Pain Med       Date:  2010 Jul-Aug       Impact factor: 6.288

7.  A Comparative Study Evaluating the Efficacy of Lignocaine and Dexmedetomidine with Lignocaine and Adrenaline in Third Molar Surgery.

Authors:  Thomson Mariadasan Dcruz; Charmiben Patel; Abhijeet Masih; Izaz Shaik
Journal:  J Maxillofac Oral Surg       Date:  2020-11-09

8.  The effect of pretreatment with clonidine on propofol consumption in opium abuser and non-abuser patients undergoing elective leg surgery.

Authors:  Morteza Jabbari Moghadam; Davood Ommi; Alireza Mirkheshti; Mehdi Shadnoush; Ali Dabbagh
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

9.  The role of continuous peripheral nerve blocks.

Authors:  José Aguirre; Alicia Del Moral; Irina Cobo; Alain Borgeat; Stephan Blumenthal
Journal:  Anesthesiol Res Pract       Date:  2012-06-18

10.  The bite of the honeybee: 2-heptanone secreted from honeybee mandibles during a bite acts as a local anaesthetic in insects and mammals.

Authors:  Alexandros Papachristoforou; Alexia Kagiava; Chrisovalantis Papaefthimiou; Aikaterini Termentzi; Nikolas Fokialakis; Alexios-Leandros Skaltsounis; Max Watkins; Gérard Arnold; George Theophilidis
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.